1900
J.A. van Rijn et al. / Journal of Organometallic Chemistry 696 (2011) 1899e1903
ligands; the phenyl-substituted diphosphine ligands used in these
investigations are shown in Fig. 1 [1,2].
ArH), 7.37e7.30 (m, 12H, ArH), 7.36e7.24 (m, 4H, ArH), 4.35 (s, 5H,
Cp), 2.78e2.50 (m, 2H, CH), 1.58e1.54 (m, 2H, CH), 1.02 (s, 3H, CH3),
0.27 (s, 3H, CH3). 31P{1H} NMR (CDCl3):
d 53.1 (s).
[FeCp(CO)(dppdmp)]Cl was obtained as a yellowish solid in
2. Experimental
a yield of 75 mg, 0.12 mmol (60%). Anal. Calcd for C35H35ClFeOP2: C,
67.27; H, 5.65. Found: C, 67.44; H, 5.91. 1H NMR (CDCl3):
d 7.76e7.72
2.1. General remarks
(m, 4H, ArH), 7.72e7.53 (m, 6H, ArH), 7.51e7.30 (m, 6H, ArH),
7.22e7.17 (m, 4H, ArH), 4.88 (s, 5H, Cp), 3.07e2.71 (m, 4H, CH2), 1.11
All reactions were performed under an argon atmosphere using
standard Schlenk techniques. Solvents were dried and distilled by
standard procedures and stored under argon. [FeCp(CO)2]2, dppm,
dppe, dppp and dppb were purchased from Acros Organics and
used as received. The ligand dppdmp was synthesized following
a literature procedure [2]. C, H determinations were performed on
a PerkineElmer 2400 Series II analyzer. 1H NMR spectra (300 MHz)
and 31P{1H} NMR spectra (121.4 MHz) were recorded on a Bruker
DPX-300 spectrometer. Chemical shifts are reported in ppm. Proton
chemical shifts are relative to TMS, and phosphorus chemical shifts
are relative to 85% aqueous H3PO4. The spectra were taken at room
temperature.
(s, 3H, CH3), 0.27 (s, 3H, CH3). 31P{1H} NMR (CDCl3):
d 54.1 (s). IR
(
nmax/cmꢀ1): 1932 (CO stretch).
[FeCpBr(dppe)] was obtained as a black solid in a yield of 87 mg,
0.15 mmol (74%). Anal. Calcd for C31H29BrFeP2: C, 62.13; H, 4.88.
Found: C, 62.49; H, 5.10. 1H NMR (CDCl3):
8.00e7.98 (m, 4H, ArH),
d
7.58e7.44 (m, 6H, ArH), 7.33e7.27 (m, 6H, ArH), 7.24e7.12 (m, 4H,
ArH), 4.16 (s, 5H, Cp), 2.52e2.36 (m, 4H, CH2). 31P{1H} NMR (CDCl3):
d
95.5 (s).
[FeCp(CO)(dppe)]Br was obtained as a yellow solid in a yield of
23 mg, 0.04 mmol (18%). Anal. Calcd for C32H29BrFeOP2: C, 61.27; H,
4.66. Found: C, 62.88; H, 5.31. 1H NMR (CDCl3):
d
7.75e7.61 (m, 4H,
ArH), 7.60e7.57 (m, 8H, ArH), 7.56e7.27 (m, 4H, ArH), 7.24e7.17 (m,
4H, ArH), 4.91 (s, 5H, Cp), 3.31e3.02 (m, 2H, CH2), 3.01e2.75 (m, 2H,
2.2. Synthetic procedures and characterization
CH2). 31P{1H} NMR (CDCl3):
stretch).
d
93.5 (s). IR (nmax/cmꢀ1): 1980 (CO
Synthesis of [FeCpX(CO)2]: The dimeric compound [FeCp(CO)2]2
was reacted according to a literature procedure [7], to obtain
[FeCpCl(CO)2], [FeCpBr(CO)2] and [FeCpI(CO)2] of which the char-
acterizations corresponded with those reported in literature [13].
General procedure for the formation of [FeCp(CO)(PP)]X and
[FeCpX(PP)]: A solution of [FeCpX(CO)2] (X ¼ Cl, Br, I) (0.2 mmol)
and the bidentate phosphine ligand (0.2 mmol) in 5 ml toluene was
refluxed for 1 h. The solution was cooled to room temperature and
filtered to yield 2 as the residue. The filtrate was evaporated to
dryness and product 3 was precipitated with hexane. Elemental
analyses of the complexes [FeCp(CO)(dppe)]I and [FeCp(CO)(dppp)]
I have been reported [14]. Crystals suitable for X-ray diffraction
were formed by slow diffusion of hexane into a solution of the
compound in dichloromethane.
[FeCpBr(dppp)] was obtained as a black solid in a yield of 37 mg,
0.10 mmol (52%). Anal. Calcd for C32H31BrFeP2: C, 62.65; H, 5.09.
Found: C, 62.76; H, 5.54. 1H NMR (CDCl3):
d 7.94e7.88 (m, 4H, ArH),
7.44e7.24 (m, 8H, ArH), 7.24e7.19 (m, 8H, ArH), 7.24e7.17 (m, 4H,
ArH), 4.98 (s, 5H, Cp), 2.45e2.35 (m, 4H, CH2), 2.19e2.15 (m, 2H,
CH2). 31P{1H} NMR (CDCl3):
d 53.1 (s).
[FeCp(CO)(dppp)]Br was obtained as a yellow solid in a yield of
34 mg, 0.09 mmol (47%). Anal. Calcd for C33H31BrFeOP2: C, 61.80; H,
4.87. Found: C, 61.70; H, 4.61. 1H NMR (CDCl3):
d 7.72e7.28 (m, 16H,
ArH), 7.27e7.09 (m, 4H, ArH), 4.84 (s, 5H, Cp), 3.01e2.75 (m, 2H,
CH2), 2.75e2.64 (m, 1H, CH), 2.35e2.15 (m, 2H, CH2), 1.85e1.61 (m,
1H, CH). 31P{1H} NMR (CDCl3):
stretch).
d
52.7 (s). IR (nmax/cmꢀ1): 1960 (CO
[FeCpBr(dppdmp)] was obtained as a black solid in a yield of
[FeCp(CO)(dppe)]Cl was obtained as a yellowish solid in a yield of
93 mg, 0.16 mmol (80%). Anal. Calcd for C32H29ClFeOP2: C, 65.95; H,
124 mg, 0.19 mmol (97%). Anal. Calcd for C34H35FeBrP2: C, 63.67; H,
5.50. Found: C, 63.55; H, 5.17. 1H NMR (CDCl3):
d 7.80e7.41 (m, 4H,
5.02. Found: C, 66.12; H, 4.88. 1H NMR (CDCl3):
d 7.77e7.70 (m, 4H,
ArH), 7.35e7.18 (m, 16H, ArH), 4.54 (s, 5H, Cp), 3.01e2.88 (m, 2H,
ArH), 7.70e7.50 (m, 6H, ArH), 7.49e7.29 (m, 6H, ArH), 7.20e7.16 (m,
CH), 1.58e1.10 (m, 2H, CH), 1.03 (s, 3H, CH3), 0.28 (s, 3H, CH3). 31P
4H, ArH), 4.85 (s, 5H, Cp), 3.07e2.78 (m, 4H, CH2). 31P{1H} NMR
{1H} NMR (CDCl3):
d 50.1 (s).
(CDCl3):
d
93.2 (s). IR (nmax/cmꢀ1): 1960 (CO stretch).
[FeCpI(dppe)] was obtained as a black solid in a yield of 95 mg,
[FeCp(CO)(dppp)]Cl was obtained as a yellow solid in a yield of
0.15 mmol (74%). Anal. Calcd for C31H29FeIP2: C, 57.61; H, 4.52.
92 mg, 0.15 mmol (77%). Anal. Calcd for C33H31ClFeOP2: C, 66.41; H,
Found: C, 57.84; H, 4.57. 1H NMR (CDCl3):
d 8.01e7.99 (m, 4H, ArH),
5.23. Found: C, 65.44; H, 5.35. 1H NMR (CDCl3):
d 7.79e7.72 (m, 4H,
7.46e7.35 (m, 6H, ArH), 7.32e7.19 (m, 6H, ArH), 7.13e7.10 (m, 4H,
ArH), 7.71e7.52 (m, 6H, ArH), 7.49e7.32 (m, 6H, ArH), 7.25e7.16 (m,
ArH), 4.20 (s, 5H, Cp), 2.71e2.59 (m, 4H, CH2). 31P{1H} NMR (CDCl3):
4H, ArH), 4.91 (s, 5H, Cp), 3.12e2.64 (m, 6H, CH2). 31P{1H} NMR
d
54.0 (s). IR (nmax/cmꢀ1): 1971 (CO stretch).
d
97.0 (s).
(CDCl3):
[FeCp(CO)(dppe)]I was obtained as a yellow solid in a yield of
[FeCpCl(dppdmp)] was obtained as a black solid in a yield of
20 mg, 0.03 mmol (15%). 1H NMR (CDCl3):
d 7.69e7.58 (m, 4H, ArH),
45 mg, 0.08 mmol (38%). Anal. Calcd for C34H35ClFeP2: C, 68.42; H,
5.91. Found: C, 68.98; H, 5.81. 1H NMR (CDCl3):
d 7.71e7.68 (m, 4H,
7.56e7.7.31 (m, 12H, ArH), 7.31e7.26 (m, 4H, ArH), 4.86 (s, 5H, Cp),
3.05e2.98 (m, 2H, CH2), 2.84e2.77 (m, 2H, CH2). 31P{1H} NMR
(CDCl3):
d
92.8 (s). IR (nmax/cmꢀ1): 1984 (CO stretch).
[FeCpI(dppp)] was obtained as a dark green solid in a yield of
56 mg, 0.09 mmol (47%). Anal. Calcd for C32H31FeIP2: C, 58.21; H,
4.73. Found: C, 58.18; H, 4.64. 1H NMR (CDCl3):
d 7.93e7.92 (m, 4H,
ArH), 7.40e7.35 (m, 8H, ArH), 7.26e7.18 (m, 8H, ArH), 4.06 (s, 5H,
Cp), 2.65e2.57 (m, 2H, CH), 2.52e2.2.48 (m, 2H, CH), 2.27e2.17 (m,
2H, CH). 31P{1H} NMR (CDCl3):
d
55.4 (s).
[FeCp(CO)(dppp)]I was obtained as a yellow solid in a yield of
37 mg, 0.05 mmol (27%). 1H NMR (CDCl3):
7.58e7.7.54 (m, 9H,
d
ArH), 7.51e7.39 (m, 8H, ArH), 7.25e7.16 (m, 3H, ArH), 4.81 (s, 5H,
Cp), 2.95e2.79 (m, 2H, CH2), 2.75e2.50 (m, 1H, CH), 2.21e2.12 (m,
2H, CH2), 1.74e1.71 (m, 1H, CH). 31P{1H} NMR (CDCl3):
d 52.6 (s). IR
Fig. 1. Bidentate phosphine ligand used in substitution studies of Fe(II)Cp(CO)-
complexes.
(
nmax/cmꢀ1): 1956 (CO stretch).